Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,036 | 42 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $169.85 | 3 | $0 (2024) |
| ABBVIE INC. | $118.01 | 5 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $85.69 | 4 | $0 (2024) |
| Gilead Sciences, Inc. | $66.63 | 3 | $0 (2024) |
| Genentech USA, Inc. | $51.09 | 2 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $45.53 | 2 | $0 (2024) |
| Daiichi Sankyo Inc. | $45.53 | 2 | $0 (2024) |
| BeiGene USA, Inc. | $44.74 | 2 | $0 (2024) |
| Lilly USA, LLC | $41.16 | 2 | $0 (2024) |
| Celgene Corporation | $40.95 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $741.01 | 34 | ABBVIE INC. ($88.85) |
| 2023 | $295.33 | 8 | Regeneron Healthcare Solutions, Inc. ($146.78) |
All Payment Transactions
42 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: ONCOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/09/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $28.80 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2024 | PFIZER INC. | INLYTA (Drug), PADCEV | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: ONCOLOGY | ||||||
| 12/03/2024 | TAIHO ONCOLOGY, INC. | LONSURF (Drug), INQOVI | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Oncology | ||||||
| 11/07/2024 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI, TUKYSA | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ALUNBRIG (Drug) | Food and Beverage | In-kind items and services | $25.38 | General |
| Category: ONCOLOGY | ||||||
| 10/31/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.63 | General |
| 10/30/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.92 | General |
| 10/23/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: Oncology | ||||||
| 09/26/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Oncology | ||||||
| 09/10/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $24.15 | General |
| Category: Hematology | ||||||
| 08/15/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: ONCOLOGY | ||||||
| 08/15/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/14/2024 | SERVIER PHARMACEUTICALS LLC | Voranigo (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: Oncology | ||||||
| 07/25/2024 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | Cash or cash equivalent | $24.48 | General |
| Category: ONCOLOGY | ||||||
| 07/18/2024 | Genentech USA, Inc. | Columvi (Biological), Lunsumio, Polivy | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: BioOncology | ||||||
| 07/11/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: Oncology | ||||||
| 07/08/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: ONCOLOGY | ||||||
| 07/02/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: Oncology | ||||||
| 06/27/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: ONCOLOGY | ||||||
| 06/13/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: Oncology | ||||||
| 06/11/2024 | Celgene Corporation | — | Food and Beverage | Cash or cash equivalent | $16.80 | General |
| 05/30/2024 | Lilly USA, LLC | VERZENIO (Drug), RETEVMO, JAYPIRCA | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Oncology | ||||||
| 05/14/2024 | Coherus Biosciences Inc. | Udenyca (Biological) | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: Granulocyte colony stimulating factor | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 137 | 186 | $39,890 | $8,875 |
| 2022 | 1 | 31 | 45 | $12,195 | $3,241 |
| 2021 | 2 | 33 | 43 | $9,502 | $2,955 |
| 2020 | 1 | 13 | 15 | $3,615 | $900.76 |
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 57 | 93 | $19,809 | $4,726 | 23.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 43 | 43 | $13,631 | $2,751 | 20.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 37 | 50 | $6,450 | $1,399 | 21.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 31 | 45 | $12,195 | $3,241 | 26.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 19 | 27 | $6,802 | $2,159 | 31.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2021 | 14 | 16 | $2,700 | $795.17 | 29.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 13 | 15 | $3,615 | $900.76 | 24.9% |
About Dr. Joan Cain, MD
Dr. Joan Cain, MD is a Hematology & Oncology healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/01/2008. The National Provider Identifier (NPI) number assigned to this provider is 1043495732.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joan Cain, MD has received a total of $1,036 in payments from pharmaceutical and medical device companies, with $741.01 received in 2024. These payments were reported across 42 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($1,036).
As a Medicare-enrolled provider, Cain has provided services to 214 Medicare beneficiaries, totaling 289 services with total Medicare billing of $15,972. Data is available for 4 years (2020–2023), covering 7 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Location Atlanta, GA
- Active Since 01/01/2008
- Last Updated 01/01/2008
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1043495732
Products in Payments
- LIBTAYO (Biological) $169.85
- EPKINLY (Drug) $48.67
- ULTOMIRIS (Biological) $45.53
- BRUKINSA (Drug) $44.74
- VERZENIO (Drug) $41.16
- LUPRON DEPOT (Drug) $40.18
- ENHERTU (Biological) $38.10
- Xermelo (Drug) $34.61
- XPOVIO (Drug) $31.37
- VENCLEXTA (Drug) $29.16
- KEYTRUDA (Biological) $28.15
- Venclexta (Biological) $27.80
- ALUNBRIG (Drug) $25.38
- TAGRISSO (Drug) $24.75
- clonoSEQ (Device) $24.48
- REBLOZYL (Biological) $24.15
- Udenyca (Biological) $23.31
- Columvi (Biological) $23.29
- INJECTAFER (Drug) $22.99
- LYNPARZA (Drug) $22.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Atlanta
Dr. Jonathon Cohen, M.d, M.D
Hematology & Oncology — Payments: $330,523
Dr. Ajay Nooka, M.d., M.p.h.,F.a.c.p, M.D., M.P.H.,F.A.C.P
Hematology & Oncology — Payments: $256,358
Dr. Rodolfo Bordoni, Md, MD
Hematology & Oncology — Payments: $240,507
Dr. Mehmet Bilen, M.d, M.D
Hematology & Oncology — Payments: $134,196
Olatunji Alese, M.d, M.D
Hematology & Oncology — Payments: $131,083
Dr. Carlos Franco, Md, MD
Hematology & Oncology — Payments: $115,439